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Multiple synaptotagmins are expressed in brain, but
only synaptotagmins I and II have known functions in
fast, synchronous Ca21-triggered neurotransmitter re-
lease. Synaptotagmin III was proposed to regulate other
aspects of synaptic vesicle exocytosis, particularly its
slow component. Such a function predicts that synapto-
tagmin III should be an obligatory synaptic vesicle pro-
tein, as would also be anticipated from its high homol-
ogy to synaptotagmins I and II. To test this hypothesis,
we studied the distribution, developmental expression,
and localization of synaptotagmin III and its closest
homolog, synaptotagmin VI. We find that synaptotag-
mins III and VI are present in all brain regions in het-
erogeneous distributions and that their levels increase
during development in parallel with synaptogenesis.
Furthermore, we show by immunocytochemistry that
synaptotagmin III is concentrated in synapses, as ex-
pected. Surprisingly, however, we observed that synap-
totagmin III is highly enriched in synaptic plasma mem-
branes but not in synaptic vesicles. Synaptotagmin VI
was also found to be relatively excluded from synaptic
vesicles. Our data suggest that synaptotagmins III and
VI perform roles in neurons that are not linked to syn-
aptic vesicle exocytosis but to other Ca21-related nerve
terminal events, indicating that the functions of synap-
totagmins are more diverse than originally thought.
Synaptotagmins represent a family of at least 12 proteins
that are thought to function in membrane traffic (reviewed in
Ref. 1). All synaptotagmins are composed of a short N-terminal
sequence that is intraluminal and/or extracellular, a single
transmembrane region, and a large cytoplasmic sequence that
contains two C2-domains (1). In all synaptotagmins, the N-
terminal sequence is translocated across the membrane during
translation but lacks a cleaved signal peptide (2, 3), and the
transmembrane regions contain multiple cysteine residues
that may be palmitoylated (4, 5). The C2-domains, the most
conserved feature of synaptotagmins (1), are separated from
the transmembrane region by a variable connecting sequence.
C2-domains are general Ca
21-binding motifs that function as
Ca21-binding modules in most synaptotagmins (reviewed in
Ref. 6). In some synaptotagmins, however, the C2-domains
contain sequence changes that probably abolish Ca21 binding
(e.g. synaptotagmins IV and XI; Refs. 3 and 7), suggesting that
C2-domains can also perform Ca
21-independent functions.
Synaptotagmins I and II, the first molecularly characterized
synaptotagmins (8, 9), are abundant synaptic vesicle proteins
that are differentially expressed; synaptotagmin I is primarily
present in rostral regions, and synaptotagmin II is primarily
present in caudal brain regions (9, 10). Knockout experiments
in mice revealed that synaptotagmin I is essential for fast
Ca21-triggered neurotransmitter release but is not required for
exocytosis as such; slow Ca21-triggered neurotransmitter re-
lease and Ca21-independent release were still functional in the
knockout animals (11). These results indicated that synapto-
tagmin I functions as a Ca21 sensor for fast synaptic vesicle
exocytosis in upper brain regions. Synaptotagmin II probably
performs an equivalent role in lower brain regions because it is
very homologous to synaptotagmin I and is also enriched in
synaptic vesicles (9, 11).
Similar to synaptotagmins I and II, synaptotagmins III-XII
are expressed primarily in brain (3, 12–17). However, the
mRNAs of most of these other synaptotagmins are detectable
at low levels outside of the brain (3, 12–17). Although the
enrichment of synaptotagmins III-XII in brain and their ho-
mology to synaptotagmins I and II led to the notion that syn-
aptotagmins III-XII may also reside on the synaptic vesicle,
their localizations and potential functions have not been inves-
tigated in detail. Synaptotagmin III is particularly interesting
because it is the most abundant synaptotagmin after synapto-
tagmins I and II and because it exhibits Ca21-binding charac-
teristics that resemble the Ca21 requirements of the slow com-
ponent of Ca21-dependent neurotransmitter release (18–20).
These findings have led to the hypothesis that synaptotagmin
III may mediate the slow component of neurotransmitter re-
lease (18). In support of this hypothesis, synaptotagmin III is
enriched in synapses, detectable in purified synaptic vesicles,
and heteromultimerizes with synaptotagmin I in vitro (10, 21).
Furthermore, in pancreatic b-cells, synaptotagmin III is pres-
ent on secretory granules and may mediate Ca21-triggered
exocytosis of these granules (22). If synaptotagmin III indeed
functions as an exocytotic Ca21 sensor similar to synaptotag-
mins I and II, it should also be on the secretory vesicles that
undergo exocytosis. However, the localization of synaptotag-
min III (or other synaptotagmins except for synaptotagmins I
and II) was not investigated systematically and quantitatively,
and its precise distribution is unknown.
In the current study, we have examined the subcellular
localization of synaptotagmin III and its closest relative, syn-
aptotagmin VI. Surprisingly, we find that synaptotagmins III
and VI are not enriched in synaptic vesicles. Instead, synapto-
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tagmin III is highly concentrated on synaptic plasma mem-
branes, and synaptotagmin VI is widely present in membranes.
Our data suggest that synaptotagmins may be functionally
more diverse than previously envisioned.
EXPERIMENTAL PROCEDURES
Production and Affinity Purification of Antibodies—Specificity tests
revealed that our previously raised antibodies against the C2-domains
of synaptotagmins III and VI (L181 and I471, respectively) weakly
cross-react with other synaptotagmins, presumably because their C2-
domains are so similar. Therefore we generated a new set of antibodies
to the sequence between the transmembrane region and the C2A-do-
main of synaptotagmins III and VI (residues 88–296 and 86–229 of
synaptotagmins III and VI, respectively (3, 12)). Rabbits were immu-
nized with glutathione S-transferase-fusion proteins (produced in the
pGEX-KG vector (23)), and the resulting sera (S754 and S756 for
synaptotagmins III and VI, respectively) were affinity-purified on im-
mobilized maltose-binding protein fusion proteins containing the same
sequences of synaptotagmins (in pMal-C2; New England Biolabs). The
specificity of all antibodies was tested by probing extracts from COS
cells transfected with individual synaptotagmins and by comparing
their reactivities with brains from wild type and knockout mice that
lack either synaptotagmin III or VI.1
Immunocytochemistry—Cryostat sections (5–15 mm) from rat and
mouse brains or bovine retina were probed with affinity-purified syn-
aptotagmin antibodies followed by horseradish peroxidase-labeled or
biotin-labeled secondary antibodies and development of the signal with
the StreptABComplex/HRP kit (DAKO) or by metal enhancement es-
sentially as described previously (24–26). The specificity of the signals
was ascertained by two controls: 1) blocking of the signal with the
recombinant protein used for antibody production, and 2) analysis of
brains from knockout mice lacking synaptotagmin III.1
Subcellular Fractionations—Rat brain homogenates were subfrac-
tionated into crude synaptic vesicles, mitochondria, myelin, and synap-
tic plasma membranes by the method of Jones and Matus (27). For this
purpose, whole brains including cerebella, olfactory bulbs, and brain
stem from 4–6-week-old rats were homogenized in ice-cold 0.32 M
sucrose using a motorized glass-Teflon homogenizer. The homogenate
was centrifuged at 800 3 g for 10 min to remove nuclei and debris, and
the resulting supernatant was re-centrifuged at 9,000 3 g for 20 min to
obtain synaptosomes and the synaptosomal supernatant. The synapto-
somes in the pellet were washed once in 0.32 M sucrose, lysed hypoton-
ically, and centrifuged at 25,000 3 g for 20 min to isolate large synap-
tosomal membranes in the pellet, whereas the free synaptic vesicles
remained in the supernatant under these conditions. The synaptosomal
membranes were resuspended in dH2O, sucrose was added to 1.1 M, and
the solution was placed at the bottom of a Beckman SW28 rotor tube.
The sample was overlaid with 0.855 and 0.32 M sucrose solutions and
centrifuged for 2.5 h at 19,000 rpm, resulting in the isolation of myelin
(in the 0.32/0.855 M sucrose interface), synaptic plasma membranes (in
the 0.855/1.1 M sucrose interface), and mitochondria (in the pellet). For
the purification of synaptic vesicles, hypotonically lysed synaptosomes
were used as a starting point for the isolation of crude synaptic vesicles
that were further purified by velocity-density gradient centrifugation
and controlled pore glass chromatography essentially as described pre-
viously (28, 29). For organelle immunoisolation, beads with immobi-
lized monoclonal antibodies to synaptotagmin I (Cl41.1) or synaptobre-
vin II (Cl69.1) and control beads containing only immobilized glycine
were prepared as described previously (30, 31). Rat brains were homog-
enized in 5 mM HEPES-NaOH, pH 7.4, 0.32 M sucrose, 0.1 mM EGTA, 1
mM phenylmethylsulfonyl fluoride, 10 mg/liter leupeptin, 1 mg/liter
pepstatin A, and 10 mg/liter aprotinin. The homogenates were centri-
fuged for 10 min at 7,800 3 g to generate a postnuclear supernatant.
Beads were incubated for 30 min at 4 °C under rotation with the
postnuclear supernatant and washed four times, and bound proteins
were analyzed by quantitative immunoblotting using 125I-labeled sec-
ondary antibodies.
Quantitative Immunoblotting—To quantitate the relative levels of
proteins in various fractions for the purification of synaptic vesicles by
subcellular fractionation or by immunobead precipitation, we reacted
immunoblots of the various fractions with 125I-labeled secondary anti-
bodies and measured the respective signals in a phosphorimager. All
blots were probed simultaneously with antibodies to the protein under
study and antibodies to synaptogyrin as an internal vesicle protein
standard (32). The synaptotagmin signals were then normalized for the
synaptogyrin signal by designating the ratio of the two signals observed
in starting brain homogenates or postnuclear supernatants as 1.0. For
the immunobead experiments, the signals obtained in pulldowns with
glycine control beads were subtracted from the values from the immu-
nobead pulldowns before the ratios were calculated.
Miscellaneous Procedures—SDS-polyacrylamide gel electrophoresis
and immunoblotting were performed using standard procedures (33,
34). Immunoblots were developed by enhanced chemiluminescence ex-
cept for the quantitative experiments described above.
RESULTS AND DISCUSSION
We raised multiple antibodies to synaptotagmins III and VI,
affinity-purified the antibodies, and tested their specificity us-
ing COS cells transfected with various synaptotagmins (data
not shown). Our initial antibodies were directed against the
C2-domains of synaptotagmins III and VI. These antibodies,
however, exhibited cross-reactivity with the more abundant
synaptotagmins I and II, thereby limiting their usefulness.
Therefore, we subsequently raised more specific antibodies us-
ing the sequence that connects the transmembrane region with
the C2-domains and varies considerably between different syn-
aptotagmins (7–10, 12–17) as an antigen. At least one of these
antibodies for each synaptotagmin was specific for that partic-
ular isoform, based on the following evidence: 1) as shown for
synaptotagmin III in Fig. 1, the antibodies specifically reacted
with the cognate protein expressed in COS cells and recognized
a single band (synaptotagmin III) or two closely co-migrating
bands (synaptotagmin VI; see below) in total brain extract; and
2) immunoblots of total brain homogenates from wild type mice
and from knockout mice lacking either synaptotagmin III or
synaptotagmin VI were analyzed (Fig. 2). The generation and
analysis of these knockout mice will be reported in a later, more
detailed report.1 The mouse immunoblots confirmed that the
synaptotagmin III antibodies reacted with a single band and
that the synaptotagmin VI antibodies reacted with a set of two
closely spaced bands in brain. In the knockouts that contain all
other synaptotagmins, the reactivity was abolished (Fig. 2).
Using these antibodies, we examined the regional distribu-
tion of synaptotagmins I, III, and VI in rat brain (Fig. 3). As
described previously (9), synaptotagmin I was expressed in
much higher levels in upper brain regions than in hindbrain
and spinal cord (which in turn synthesize higher levels of
synaptotagmin II). CASK as a general synaptic marker was
uniformly present in all brain regions (35, 36). The expression
of synaptotagmins III and VI, however, exhibited a different
1 R. Fernandez Chacon, R. E. Hammer, and T. C. Su¨dhof, unpub-
lished observation.
FIG. 1. Characterization of synaptotagmin III antibodies. Pro-
teins from COS cells transfected with control DNA (lane 1) or with a rat
synaptotagmin III expression vector (lane 2) and rat brain homogenates
(lane 3) were analyzed by immunoblotting with affinity-purified anti-
bodies to synaptotagmin III. Signals were visualized by ECL. Note that
in brain only a single band is apparent; the low abundance, smaller
proteins in lane 2 probably represent proteolytic breakdown products.
Numbers on the left indicate positions of molecular mass markers.
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pattern: both synaptotagmins were present in all brain regions
but displayed large regional variations. Synaptotagmin III was
almost undetectable in the cerebral cortex and olfactory bulb
but was highly expressed in the hippocampus and cerebellum.
In addition, it was present at moderate levels in spinal cord and
hindbrain (Fig. 3). Synaptotagmin VI was synthesized at
rather low levels in all brain areas except for the olfactory bulb,
which contained exceptionally high levels of this isoform.
Previous data suggested that synaptotagmin III is localized
to synapses (10). This result was supported in the current
study by two independent observations. First, we examined the
developmental expression profile of synaptotagmins. The level
of synaptic vesicle proteins goes up dramatically postnatally in
parallel with synaptogenesis (37). When we analyzed brain
proteins from rat forebrain as a function of age, we found that
synaptotagmin I levels increased postnatally, as expected (10)
(Fig. 4). By contrast, the general trafficking protein rab5 ex-
hibited only a moderate developmental change. Synaptotag-
mins III and VI, similar to synaptotagmin I, experienced a
striking postnatal increase in levels that paralleled the time
course of synaptotagenesis (Fig. 4). In adults, the levels of
synaptotagmin VI, but not synaptotagmins I and III, decreased
slightly. Two closely migrating bands were observed for synap-
totagmin VI that may be due to alternative splicing; the mo-
lecular basis for this heterogeneity is unclear.
The second observation confirming a synaptic localization of
synaptotagmin III was obtained by immunocytochemistry. Un-
fortunately, the quality of our synaptotagmin VI antibodies
precluded a morphological localization; even the signal for syn-
aptotagmin III in immunocytochemical stains was insufficient
to allow immunoelectronmicroscopy. At the light level, how-
ever, synaptotagmin III was present in a pattern strongly
suggestive of a synaptic localization (Fig. 5; data not shown).
This was most clear in the retina, which contains two sharply
delineated synaptic layers, the thin outer plexiform layer com-
posed of photoreceptor synapses and the broader inner plexi-
form layer comprising multiple sublayers of synapses (38).
Synaptotagmin III was highly concentrated in the two synaptic
layers in the retina, similar to synaptotagmin I (Fig. 5). The
FIG. 2. Definition of antibody specificity to synaptotagmins III
and VI by immunoblot analysis of brains from wild type mice
and from knockout mice lacking synaptotagmins III (A) or VI
(B). Brain homogenates from the indicated mice were immunoblotted
with affinity-purified antibodies to synaptotagmins III (A) and VI (B).
Note that the immunoreactive bands are absent in the knockout mice,
indicating that the antibodies we raised are highly specific for those
particular isoforms.
FIG. 3. Heterogeneous regional expression of synaptotagmins
I, III, and VI in rat brain. Equivalent amounts of protein from the
indicated brain regions were analyzed by immunoblotting with antibod-
ies to synaptotagmins I (Syt I), III (Syt III), and VI (Syt VI) and to
synaptogyrin I (Syg I) and CASK. Note the contrast between the rela-
tively uniform expression pattern of CASK, the striking rostral-caudal
gradient of synaptotagmin I, and the heterogeneous distributions of
synaptotagmins III and VI. The arrow in the synaptotagmin I blot
identifies the full-length protein, and the asterisk identifies the major
proteolytic breakdown product of this protein (2). Signals were visual-
ized by ECL. The synaptotagmin VI doublet is not resolved in the
percentage of acrylamide used for this gel (see Fig. 2).
FIG. 4. Developmental time course of the expression of synap-
totagmins I, III and VI. Brain homogenates from rats of embryonic
day 19 (E19) and postnatal days 1–18 (P1–P18) and from adult rats
were analyzed by immunoblotting with ECL detection using antibodies
to synaptotagmins I (Syt I), III (Syt III), and VI (Syt VI) and rab5.
Positions of molecular mass markers are shown on the left.
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only difference between synaptotagmins I and III was that in
the inner plexiform layer, synaptotagmin I was present
throughout the synaptic zone, whereas synaptotagmin III was
enriched in a few sharply delineated sublayers (Fig. 5). These
data confirm that synaptotagmin III is highly enriched in
synapses.
Because synaptotagmins I and II are known stoichiometric
components of synaptic vesicles (1) and are highly homologous
to synaptotagmins III and VI (3, 12), a logical presumption is
that synaptotagmins III and VI are also vesicle proteins. This
is supported by the finding that all synaptotagmins are co-
enriched in brain, where they appear to be concentrated in the
synapses, and that at least some synaptotagmin III protein can
be detected in the vesicles (10, 12). However, the relative dis-
tributions of synaptotagmins between various brain fractions
was never quantitatively examined. Therefore, we studied this
question systematically by subcellular fractionation (Fig. 6). As
expected, synaptotagmin I was enriched in two fractions: 1)
free synaptic vesicles (Fig. 6, lane 6), and 2) synaptic plasma
membranes that contain active zones with firmly docked vesi-
cles (lane 7). Synaptotagmin III was also detectable in free
synaptic vesicles but, surprisingly, was not enriched in the
vesicles (Fig. 6, lane 6). Instead, it was highly concentrated in
synaptic plasma membranes (lane 7). The pattern of synapto-
tagmin III closely resembled that of neurexins, which are
known components of the presynaptic plasma membrane (39).
Synaptotagmin VI was evenly present in all fractions and was
also not particularly enriched in synaptic vesicles. The distri-
butions of synaptogyrin I as an additional synaptic vesicle
marker (32) and of complexins as a marker for the cytosol (40)
were analyzed as controls in the same blots and found to be
localized in the appropriate fractions (Fig. 6).
The subcellular fractionation data raised the possibility that
synaptotagmin III, although present in synapses, may not ac-
tually be a synaptic vesicle protein. To test this hypothesis, we
performed systematic studies on the enrichment of synaptotag-
mins with synaptic vesicles. We used two complementary tech-
niques in these studies: 1) purification of synaptic vesicles by
CPG2 chromatography (Fig. 7), which is widely accepted as the
method that yields the most highly purified vesicles (28, 29),
and 2) immunoprecipitation of synaptic vesicles by antibodies
to synaptotagmin I or synaptobrevin II (Fig. 8), which allows
separation of the synaptic vesicles from similarly sized or-
ganelles (30, 31).
First, we examined the levels of various synaptotagmins by
quantitative immunoblotting in four fractions obtained during
the isolation of highly purified vesicles. In this purification
procedure, starting homogenate (Fig. 7, lane 1) is used to purify
2 The abbreviation used is: CPG, controlled pore glass.
FIG. 5. Localizations of synaptotagmins I and III in retinal
synapses. Cryostat sections of bovine retina were probed with antibod-
ies to synaptotagmin I (A and B, control without primary antibody) or
synaptotagmin III (C and D, control with synaptotagmin III antibody
and recombinant synaptotagmin III as a blocking agent). Signals were
developed with biotin-labeled secondary antibodies and streptavidin
ABC complexes. Synaptic layers are identified on the left. OPL, outer
plexiform layer; IPL, inner plexiform layer. Scale bar, '50 mM.
FIG. 6. Analysis of the distributions of synaptotagmins in rat
brain by subcellular fractionation. Fractions were immunoblotted
with antibodies to the proteins indicated on the right; the bottom panel
exhibits a Coomassie Blue-stained SDS-gel of the same factions. Molec-
ular masses are indicated on the left.
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synaptosomes (lane 2) that yield free synaptic vesicles (lane 3;
see also Fig. 6) that are further purified by CPG chromatogra-
phy (lane 4). Coomassie Blue-stained SDS-gels revealed that
the protein composition of synaptic vesicles changed dramati-
cally upon purification of the vesicles by CPG chromatography
(data not shown). We then measured the relative enrichment of
various synaptotagmins by immunoblotting with 125I-labeled
secondary antibodies and phosphorimager detection; all blots
were probed for synaptogyrin as an internal standard. Data
were calculated as the signal ratios of the protein of interest to
synaptogyrin I. For the purpose of normalization, the ratio
observed in the starting fraction was set as 1.0. As expected,
the abundance of synaptotagmin I and synaptogyrin I, two
known vesicle proteins, increased in parallel during purifica-
tion; thus, their ratio remained constantly close to 1.0 (Fig. 7B).
Synaptotagmins III and VI, however, did not increase with
synaptotagmin I during synaptic vesicle preparation; their ra-
tio to synaptogyrin decreased significantly in pure synaptic
vesicles (Fig. 7B). These results suggest that synaptotagmins
III and VI are not obligatory vesicle components but de-enrich
from the vesicles.
To confirm this unexpected result by an independent
method, we performed experiments in which organelles were
immunoisolated from rat brain homogenates with beads coated
with antibodies to either synaptotagmin I or synaptobrevin II,
which are known synaptic vesicle proteins. As a control, incu-
bations were performed with beads that were coated only with
glycine (30, 31) (Fig. 8A). The resulting fractions were again
analyzed by quantitative immunoblotting, and the signals ob-
tained for glycine beads were subtracted from the synaptotag-
min I or synaptobrevin II bead signals. As in the biochemical
preparations, we normalized all results for synaptogyrin ana-
lyzed on the same gels. As before, immunoisolation dramati-
cally increased the levels of synaptotagmin I and synaptogyrin
I in the samples, and their ratio remained constant. In con-
trast, a quantitative loss of synaptotagmins III and VI from the
immunoisolated vesicles was observed; their ratio to synapto-
gyrin decreased significantly in the immunisolated samples.
(Fig. 8B). The two kinds of beads coated with the different
antibodies gave identical results, thereby confirming each
other.
Conclusion—Synaptotagmins are a large family of homolo-
gous proteins that are enriched in brain and thought to func-
tion in Ca21-regulated membrane traffic. Although synaptotag-
mins I and II have known functions in synaptic vesicle
exocytosis, little is known about the localizations, properties,
FIG. 7. Relative levels of synapto-
tagmins I, III, and VI in synaptic ves-
icles purified by CPG chromatogra-
phy. A, immunoblotting analysis of the
four major fractions obtained during the
isolation of highly purified synaptic vesi-
cles (CPG Vesicles). Signals for synapto-
tagmins III and VI (Syt III and Syt VI) are
relatively weak because an autoradio-
gram of a blot reacted with 125I-labeled
secondary antibodies is shown that is less
sensitive than ECL detection. Equivalent
exposures for all synaptotagmins are de-
picted, leading to an overexposure of the
synaptotagmin I (Syt I) and synaptogyrin
I (Syg I) blots. B, quantitation of the rel-
ative enrichment of synaptotagmins I, III,
and VI in synaptic vesicles isolated by
CPG column chromatography. Blots were
reacted with antibodies to either synapto-
tagmin I, III, or VI and to synaptogyrin I
followed by 125I-labeled secondary anti-
bodies. The ratio of the synaptotagmin to
synaptogyrin signal was quantified on a
phosphorimager and set at 1.0 for the
starting homogenate. Data shown are
from three independent experiments (TH,
total brain homogenate; P2, synapto-
somes; LP2, LP2 vesicles obtained from
synaptosomes; CPG, synaptic vesicles pu-
rified by CPG chromatography).
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and functions of the other synaptotagmins. In the current
study, we examined the localizations of synaptotagmins III and
VI. Unexpectedly, we have found that synaptotagmin III, al-
though synaptic, is not on synaptic vesicles, and that synapto-
tagmin VI also fails to co-purify with synaptic vesicles. Our
data suggest that the functions of nerve terminals must involve
other, as yet unidentified Ca21-regulated membrane traffick-
ing pathways that involve these synaptotagmins. The high
concentration of synaptotagmin III in synaptic plasma mem-
branes raises the possibility that this isoform may, in fact, not
be on an intracellular vesicle but may be localized to the
plasma membrane. One possibility is that synaptotagmin III is
a plasma membrane protein that could regulate the expansion
of presynaptic plasma membranes as a function of activity;
another possibility is that an as yet unidentified organelle
co-purifies with synaptic plasma membranes and represents
the true localization of this isoform. Future experiments will
have to test this and other possible hypotheses about what the
functions of these proteins might be in synapses that do not
directly involve synaptic vesicles.
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